Celularity Celularity
  • Home
  • About
    • About Us
    • Leadership
    • Board of Directors
    • Scientific Advisors
    • Manufacturing
    • Biobanking
    • Tour Our Facility
    • Expanded Access Policy
  • Science
    • Power of Placenta
    • NK Cell Platform
    • T Cell Platform
    • Exosomes
    • Advanced Biomaterials
  • Pipeline
  • Newsroom
  • Investors
    • Investor Relations
    • SEC Filings
    • Corporate Governance
  • Careers
Celularity
MENU

Biobanking in our state-of-the-art, integrated facility employing the latest in vapor-phase liquid-nitrogen storage.

img1

Industry Leading Cryopreservation

Over 20 years of experience employing industry leading cryopreservation technology.

img3

Unique Retrieval Technologies

Proven procurement systems and technologies enable the collection of the highest number of cells possible.

img2

Placenta and Umbilical Cord Blood

Proprietary methods allow us to derive cells and biomaterials from these vital sources.

img4

Biobanking Options

An array of private banking options for families including cord tissue and placental tissue.

Pioneers in Stem & Therapeutic Cell Preservation

“Our team of scientists and engineers continue to lead innovation in cellular medicine, enabling Celularity to offer a comprehensive array of placental-derived stem and immune cells as well as tissue derived products. Using ‘Nature’s Toolkit,’ we can offer families the potential to unlock existing and emerging medical treatments as they become available.”

– Robert J. Hariri, Founder & CEO

Over 20 Years of Biobanking Experience

We are pioneers in retrieving life-saving stem cells from placenta and umbilical cord blood, with extensive experience deploying these tools to treat a range of diseases.

Strict Attention to Quality

All procured materials are rigorously inspected and tested using proven protocols and methodologies developed by our scientific and technical operations experts.

On-Site Storage

All materials are stored in our on-site vapor-phase liquid-nitrogen storage tanks, which are monitored continuously 24/7/365.

Learn more about our private client biobanking business that has operated since 1998.

Visit LifebankUSA.com
Celularity_Nasdaq_CELU-1

Celularity is a biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells (ASCs), targeting indications across cancer, immunologic, infectious, and degenerative diseases.

Company

  • About
  • Leadership
  • Board of Directors
  • Scientific Advisors
  • Tour Our Facility
  • Careers

Science

  • Pipeline
  • NK Cell Platform
  • T Cell Platform
  • Lifebank
  • Advanced Biomaterials
  • Manufacturing

Investors

  • Investor Relations
  • Partnerships
  • SEC Filings
  • Corporate Governance
  • Press Releases

Celularity Inc. © 2025. All rights reserved.     Privacy Policy     Terms & Conditions

Company
  • About
  • Leadership
  • Board of Directors
  • Scientific Advisors
  • Tour Our Facility
  • Careers
Science
  • Pipeline
  • NK Cell Platform
  • T Cell Platform
  • Lifebank
  • Advanced Biomaterials
  • Manufacturing
Investors
  • Investor Relations
  • Partnerships
  • SEC Filings
  • Corporate Governance
  • Press Releases

Celularity Inc. © 2024. All rights reserved.
Privacy Policy     Terms & Conditions